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Abstract
Stress and stress-related disorders are emerging as a major health challenge. 
In the classical stress concept, stress can be broadly defined as an actual or antici-
pated disruption of homeostasis by certain physical and psychological events that 
are known as ‘stressors’. Prolonged exposure to stress can lead to a destructive, 
self-perpetuating cascade of neuroendocrine, metabolic and neuropsychologi-
cal alterations that play an important role in the development and progression of 
cardio-vascular disease (CVD) like hypertension. Dysregulation of stress system 
is causally linked to pathogenesis of essential hypertension, which involves over 
activity of hypothalamic-pituitary-adrenal axis (HPA) and sympathoadrenal 
system (SAS) and resetting of baroreceptors as the underlying pathophysiological 
mechanisms. Evidence suggests that regular practice of yogasanas and pranayama 
appears to cause down-regulation of the HPA axis and the sympathetic nervous sys-
tem (SNS), increases vagal activity, improves baroreceptor sensitivity, and thereby 
helps to reduce blood pressure. Although the exact mechanism of beneficial effects 
of yoga are not known, evidence suggests that yogic intervention may be acting 
through multiple mechanisms simultaneously influencing diverse neural structures 
involved in the regulation of the neuroendocrine and the cardiovascular response 
to stress to cause neurohumoral modulations resulting in alleviation of stress and 
improvement in cardiovascular indices.
Keywords: stress, hypertension, hypothalamic-pituitary-adrenal axis, 
sympathoadrenal system, baroreceptors, yoga
1. Introduction
Fast pace of life, growing aspirations of people, peer pressure and collapsing 
social support institutions like family, are affecting peoples’ health in modern 
society. Stress and stress-related disorders are emerging as a major health challenge 
across the globe. Stress is perceived as an event or experience that invoke a range of 
unpleasant emotions like uneasiness, nervousness, anxiety, and fear. More scientifi-
cally speaking stress is a state of disharmony or threatened homeostasis provoked 
by psychological, environmental, and/or physiological factors called ‘stressors’. 
Stress is often implicated in the pathogenesis of non-communicable diseases like 
hypertension, coronary heart disease, depression, and obesity. Evidence suggests 
that dysregulation of stress system is causally linked to the pathogenesis of essential 
hypertension, with over activity of Hypothalamic-pituitary-adrenal axis (HPA) and 
Sympathoadrenal System (SAS) and resetting of baroreceptors as the underlying 
pathophysiological mechanisms.
Non-pharmacological interventions such as relaxation techniques in the form of 
yoga and meditation are slowly gaining recognition as an adjunctive therapy in case 
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of stress-related health disorders like hypertension, anxiety, and depression. Yoga 
promises to be one of the best and relatively safest methods to counter stress. The 
most popularly used yoga intervention techniques include yogasanas (yoga pos-
tures) and pranayama (controlled breathing techniques) and meditation. Asanas 
and pranayamas reduce stress, relax and revitalise body. Relaxation helps to control 
anxiety, calms mind and brings down heart rate and blood pressure.
2. Concept of stress, allostasis and allostatic load
All living organisms strive towards a dynamic equilibrium, which is called 
homeostasis. Homeostasis is maintenance of relative stability of the core parameters 
required for cell survival [1]. In the classical stress concept, stress can be broadly 
defined as an actual or anticipated disruption of homeostasis by certain physical 
and/or psychological events that are known as ‘stressors’ [2].
Modern concept of stress defines it as a consciously or unconsciously perceived 
threat to homeostasis [3], which involves specific response of the body that in 
turn depends on the factors like the nature of the challenge to homeostasis, the 
perception of the stressor and the ability to cope with it [4]. A new concept called 
‘allostasis’ was introduced to define and explain stress. Accordingly, the term 
allostasis refers to the process whereby an organism maintains physiological stabil-
ity by changing parameters of its internal milieu by matching them appropriately 
to environmental demands [5, 6]. Thus, homeostasis is a process that keeps us alive 
whilst allostasis is a process that helps us to adapt to the environmental challenges.
Allostatic load (AL) refers to the cumulative effects of chronic and acute stress 
on the body. It represents the ‘wear and tear’ the body experiences when repeated 
allostatic responses are activated during stressful situations [7]. Allostatic overload 
is the final stage of the progression of allostatic load, whereby the culmination of 
physiological dysregulations both at the cellular and organ levels leads to disor-
dered, diseased, and deceased endpoints [8].
The concepts of allostasis, allostatic load and overload are to be understood in 
the context that the physiological systems involved in allostatic responses help us 
to adapt to challenges imposed by stressors and the dysregulation or overuse of the 
same systems due to prolonged exposure to stressors can lead to pathological disor-
ders [7]. Thus, allostasis involves health protective adaptive responses to stressors, 
whereas, allostatic load is the result of the overuse or dysregulation of the systems 
involved in allostatic responses that leads to pathological disorders, a state referred 
to as allostatic overload [6].
3. Neurobiology of stress response
The stress response involves multiple organ systems of the body like central 
nervous system (CNS), autonomic nervous system (ANS), endocrine system, 
cardiovascular system and immune system [9]. However, individual’s response to 
stressors is conditioned by the genetic, environmental and developmental factors. 
The collective stress responses are mediated by largely overlapping circuits in the 
hypothalamus, the limbic cortex, and many neural elements in the brainstem [10]. 
The brain triggers stress responses that are commensurate with the nature of the 
stressor. Accordingly, stress regulatory neuro-circuits activated by a particular 
stressor are crucially dependent on stressor attributes [2].
Depending on their nature, the stressors can be broadly divided into two 
categories: Physical or Physiological stressors and Psychogenic or Psychological 
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stressors. Stressors that produce actual disturbances of homeostasis are considered 
as physical stressors, e.g. haemorrhage or infection. Whereas, stressors that threaten 
the current state and are predicted or anticipated based on prior experiences are 
considered as psychogenic stressors, e.g. aversive environmental stimuli [11]. Thus, 
physical stressors represent ‘Systemic stressors’ which are of immediate survival 
value and are mainly processed by brainstem and hypothalamic regions [2, 11]. 
By contrast, ‘Psychogenic stressors’ represent ‘Processive’ stressors. They require 
sequential stimulus assembly and processing of signals from multiple sensory 
modalities in the forebrain and can occur in anticipation of or in reaction to stress-
ful events prior to initiation of a stress response. They involve the ‘Limbic stress 
pathways’ for processing information [12]. The vast majority of decisions regarding 
the initiation of stress responses seem to be made at the level of limbic structures, 
which communicate information to subcortical sites positioned to interface with 
ongoing homeostatic feedback [13]. It is also believed that limbic forebrain regions 
may also contribute to processing of physical stressors, influencing the autonomic 
responses to stress and the activation of the HPA-axis [2].
3.1 Brainstem circuitry in stress response
The autonomic nervous system (ANS) provides the immediate response to 
stressors mainly mediated via brainstem circuitry. The brainstem region receives 
neuronal inputs carrying signals of homeostatic disturbances involving cardiovas-
cular system (CVS), respiratory system (RS) and visceral organs [14], which cause 
reflex stimulation of sympathetic response [15]. Reflex sympathetic activation 
represents the classic ‘fight or flight’ response to stress [2].
Besides this, signals from medulla and spinal cord are sent to other autonomic 
regulative sites in the hindbrain, midbrain and forebrain. The complex interplay 
between these neural structures and the descending signals from the hypothalamus 
and limbic cortex ultimately modulate the autonomic response to stressors [15].
Homeostatic imbalance also triggers signals to the brainstem leading to activa-
tion of the HPA axis. Ascending brainstem pathways project to the paraventricular 
nucleus of the hypothalamus (PVN). Catecholaminergic projections to the PVN 
originate in the nucleus of the solitary tract (NTS) and C1-C3 regions and represent 
a major HPA excitatory pathway, promoting corticotropin releasing hormone 
(CRH) and thereby, adrenocorticotropic hormone (ACTH) release [16]. NTS 
projections to PVN also release neuropeptide Y, glucagon-like peptide 1, inhibin β, 
somatostatin and enkephalin, that can regulate HPA activation [17].
Ascending catecholaminergic pathways mainly mediate systemic-stress 
responses [14]. However, some non-catecholaminergic NTS cell groups (e.g. gluca-
gon-like peptide 1 neurons) are involved in the generation of HPA responses to both 
psychogenic and systemic stressors [18]. Thus, NTS appears to be a common site 
for integration of reactive HPA responses. Neurons throughout NTS are activated 
by a variety of acute and chronic stressors [19]. In addition to sending projections 
that target subcortical limbic regions critical for regulating behavioural responses 
to stress, NTS also receives direct input from the amygdala, the bed nucleus of stria 
terminalis (BST), and the prefrontal cortex [20]. Thus, NTS is a critical hub for 
integrating interoceptive and viscero-sensory input with descending affective and 
cognitive information from the limbic forebrain.
3.2 Hypothalamic nuclei
Paraventricular nucleus of the hypothalamus (PVN) acts as a principal integra-
tor of stress signals and is directly involved in regulating HPA axis and autonomic 
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responses to stressors [2]. As mentioned earlier, the PVN receives its major adrener-
gic inputs from the A2/C2 regions of NTS, which represents a major HPA excitatory 
pathway promoting CRH release [16]. The PVN neurons project to the autonomic 
targets in the brainstem and spinal cord such as the intermediolateral cell column, 
the parabrachial nucleus, the dorsal motor nucleus of the vagus nerve and the NTS 
[13]. PVN also receives serotonergic innervation from the median raphe nuclei in 
the midbrain. Serotonin activates the HPA axis and stimulates ACTH release and 
secretion of glucocorticoids (GCs) [21].
Many of the hypothalamic regions interact with the limbic inputs and are 
involved in homeostatic integration. Hypothalamic communications with limbic 
cortex and their combined downward effect on the HPA and ANS activity modulate 
responses to stressors with respect to ongoing physiological state.
PVN is heavily innervated by inhibitory GABAergic inputs from limbic regions 
[22]. Most of these limbic–PVN connections are indirect and are made through the 
bed nucleus of stria terminalis (BST) and peri-PVN regions of the hypothalamus, 
enabling it to translate limbic information into modulation of the HPA axis or auto-
nomic activation [23]. While PVN projecting GABAergic neurons from posterior 
BST nuclei inhibit HPA response to stress, CRH neurons from anteroventral BST 
nuclei to PVN are responsible for excitation of HPA activity [24].
PVN also receives inhibitory GABAergic innervation from the medial preoptic 
hypothalamus (mPoA), which receives projections from the hippocampus and the 
medial nucleus of amygdala (MeA) and is an important site for interaction between 
limbic inputs and physiological regulatory processes [2].
Lateral hypothalamic neurons are positioned to modulate autonomic and/or 
HPA tone [2, 25]. The Dorsomedial hypothalamus (DMH) regulates autonomic 
and perhaps also HPA axis responses to psychogenic stimuli [2]. Suprachiasmatic 
nucleus (SCN) has effect on the diurnal variations and basal HPA activity and auto-
nomic responses to psychogenic stressors [26]. SCN innervates peri PVN regions, 
where it interacts with the signals from limbic cortex.
3.3 Limbic stress circuits
The interface between the incoming sensory information about the stressors and 
the appraisal process is formed by limbic brain structures. Both psychogenic and 
physical stimuli are processed in multiple limbic forebrain structures, including the 
amygdala, the hippocampus and the prefrontal cortex [2]. These regions receive 
associational information from subcortical and cortical areas involved in higher-
order sensory processing and memory and also ascending inputs from sites involved 
in attention and arousal. Limbic structures do not communicate directly with the 
primary stress effector systems. Instead, they send signals to the subcortical relay 
sites, which in turn interface with the primary stress effector neurons in the PVN, 
caudal medulla and spinal cord [14]. Usually, there is interaction between the out-
puts from the stress-excitatory structures (central (CeA) and medial (MeA) nuclei 
of amygdala and infralimbic cortex) and stress-inhibitory regions (hippocampus, 
prelimbic cortex), so that local integration of limbic information occurs before 
relaying it to the primary stress effector sites [14]. Downward signals from these 
limbic regions modulate the activity of the HPA axis and probably also autonomic 
responses to stress [2].
3.3.1 Amygdala
Studies suggest that the Central nucleus of amygdala (CeA) and the BST 
coordinate to orchestrate both acute and chronic responses to various kinds of 
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threatening stimuli and are involved in the control of fear and anxiety [27]. 
CeA is primarily involved in behavioural, autonomic and endocrine responses 
to stress [10]. The medial nucleus of amygdala (MeA) and basolateral nucleus of 
amygdala (BLA) are preferentially activated by psychological stressors [11, 25]. 
There is a two-way neural communication between amygdala and the dorsal 
raphe nucleus and catecholaminergic nuclei in the brainstem. CeA sends inputs 
to CRH neurons in the PVN both directly and through the bed nucleus of the 
stria terminalis and mediates the adrenocortical response to somatosensory 
stimuli [2, 10].
3.3.2 Hippocampus
The hippocampus inhibits the HPA axis activity. It also influences autonomic 
tone. Hippocampus has no major direct projections to the brainstem, but its action 
on autonomic function might be routed through NTS-projecting regions of the 
medial prefrontal cortex (mPFC) [2].
3.3.3 Prefrontal cortex (PFC)
Prefrontal cortex (PFC) is critical to develop appropriate responses to environ-
ment changes, enabling behavioural plasticity [28]. The prelimbic medial PFC 
(mPFC) preferentially inhibits HPA axis response to psychogenic stressors and, like 
the hippocampus it is involved in response termination [2]. The infralimbic PFC 
is involved in initiating autonomic and HPA responses to psychogenic stimuli. The 
infralimbic cortex is selectively involved in stress induced cardiovascular regula-
tion, perhaps through modification of the baroreflex activity. As a result of its 
interconnections with the hippocampus and the amygdala, the prefrontal cortex is 
positioned at the top of the response initiation hierarchy and might be a principal 
limbic coordinator of physiological reactivity [2].
3.4 Circumventricular organs (CVO)
PVN projections from subfornical organ (SFO) are angiotensinergic and also 
promotes CRH secretion and biosynthesis [29]. This pathway may be involved in 
fluid/electrolyte balance stress induced stimulation of HPA-axis activity via activa-
tion of the angiotensin II type-1 receptor [30]. There are projections from organum 
vasculosum of the lamina terminalis (OVLT) to the anteroventral preoptic nucleus, 
DMH and preautonomic PVN. These pathways are believed to be responsible for 
initiating cardiovascular response to stress [31].
4. Primary mediators of stress response
The body’s responses to stressors are mediated by an intricate stress system, 
which includes the hypothalamic–pituitary–adrenal (HPA) axis and the sympatho-
adrenal system (SAS), which consists of sympathetic nervous system (SNS) and 
adrenomedullary system (AS) [32]. The hormones of HPA axis and catecholamines 
released by SAS are the primary mediators of the stress response [33].
As mentioned earlier the paraventricular nucleus of hypothalamus (PVN) 
plays a major role in stress response. Stress induced activation of the parvocel-
lular neurons of the PVN causes the release of CRH and Arginine vasopressin 
(AVP) and initiates the endocrine response to stressors. CRH controls ACTH 
release from the anterior pituitary gland [10]. AVP is co-localised with CRH in 
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parvocellular neurons of PVN. In the anterior pituitary, AVP potentiates the 
effect of CRH on ACTH release [34]. Reciprocal connections exist between CRH 
neurons in PVN and noradrenergic neurons in the locus ceruleus (LC); hence, 
they stimulate each other in a positive feedback fashion [33]. CRH serves as a 
neurotransmitter that mediates sympathetic arousal, providing a link between 
the adrenocortical and autonomic branches of the stress response. The locus 
ceruleus-norepinephrine system (LNE) controls the stress-induced stimulation of 
the sympathoadrenal system (SAS) [10]. ACTH is the key regulator of glucocorti-
coid secretion from the adrenal cortex. Glucocorticoid hormones, mainly cortisol 
in humans, and cortisone in animals, are the final effectors of the hypothalamic-
pituitary-adrenal axis (HPA) axis, which mediate the response of the organism to 
stressors [10].
5. Acute vs. chronic stress response: protection vs. damage
The first phase of the acute stress response involves activation of sympathoad-
renal system (SAS), which results in a typical ‘fight-or-flight’ responses. These are 
rapid but short-term physiological adaptations, so as to meet the challenge imposed 
by a stressful event. It is mediated by the release of catecholamines like norepi-
nephrine (NE). Whereas, the secondary phase involves the hormonal mechanism 
(hypothalamic-pituitary-adrenal axis) considered sluggish compared to the synap-
tic mechanisms that activate the SAS, but resulting in an amplified and protracted 
secretory response involving stress hormones like CRH, ACTH and glucocorticoids 
(GCs), mainly cortisol in human beings (long-lasting response). Cortisol in turn 
has effects all over the body including brain [13].
In acute stress response, the action of SAS and HPA axis mediators is protec-
tive in nature and is geared to enable the individual to adapt to stressors. However, 
chronic exposure to stressors results in over-activation and or dysregulation of 
SAS and HPA-axis to induce a chain reaction of deleterious effects on the biologi-
cal systems involved in stress response, which eventually leads to stress-related 
disorders [35]. Stress induced brain changes further diminish the body’s ability to 
cognitively process and physiologically respond to stressors [36]. In chronic stress, 
prolonged and synergistic effects of the stress hormones and pro-inflammatory 
cytokines adversely affect multiple interconnected organ systems (autonomic, 
neuroendocrine, immune and cardiovascular systems) involved in stress response, 
which finally results in various pathological conditions [8].
6. Aetiology of essential hypertension
Essential hypertension is a multifactorial disorder with a strong genetic pre-
disposition. Multiple studies have suggested involvement of many factors in the 
genesis of essential hypertension. The principal factors among them are: increased 
activity of SNS including renal SNS; over activity of renin-angiotensin-aldosterone 
system (RAAS); positive sodium imbalance; low levels of vasodilators, like nitric 
oxide (NO), prostacyclin (PGI2), and the natriuretic peptides; high levels of vaso-
constrictors like endothelin 1 (ET 1); structural and functional vascular defects; 
increased activity of vascular growth factors; and obesity [37]. In recent studies, 
oxidative stress, endothelial dysfunction, vascular remodelling and decreased vas-
cular compliance are implicated as the primary antecedents, which may be involved 
in the development of essential hypertension [38].
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7. Role of stress in pathogenesis of essential hypertension
Due to the complexity of the mechanisms controlling blood pressure regulation 
and involvement of many interconnected regulatory organ systems, with various 
endogenous and exogenous factors interacting with these regulatory systems, the 
exact cause of essential hypertension is still not known [39].
Although stress is clearly implicated in the aetiology of essential hyperten-
sion, the relationship between a psycho-physiological construct like stress and 
the physical manifestation of essential hypertension is not simple or direct. It is 
quite likely that multiple etiologic pathways as well as the variety of intervening 
variables exist that lead to the onset of essential hypertension. However, psycho-
logical stress has been considered to be one of the major risk factors for essential 
hypertension [40–42].
7.1 Cardiovascular reactivity and essential hypertension
There have been many studies which suggest that, the exaggerated cardiovas-
cular response (CVR) to life stressors appear to play a key role in the stress–hyper-
tension relation [43, 44]. It has been suggested that, heightened cardiovascular 
reactivity could reflect sympathetic hyper responsivity or enhanced vagal 
withdrawal during stress, whereas poorer cardiovascular recovery could be due to 
prolonged sympathetic activation, diminished vagal tone, or attenuated or delayed 
vagal rebound following the termination of stress [45]. It is believed that increased 
cardiovascular reactivity and poor cardiovascular recovery could indicate auto-
nomic dysregulation of cardiovascular system, which may be contributing in the 
pathogenesis of essential hypertension [46].
7.2 Chronic stress and essential hypertension
Evidence suggests that chronic exposure to psychosocial stress leads to the 
onset of essential hypertension via stress response, which includes the affective, 
cognitive, behavioural, and physiological alterations. Stress induced increased 
sympathetic activity, decreased vagal activity, reduced baroreflex gain, over activity 
of the hypothalamic-pituitary-adrenal (HPA) axis and endothelial dysfunction as a 
long-term consequence, cause increase in blood pressure and heart rate by affecting 
central and peripheral regulation of the CVS [47].
There is a mount of evidence linking chronic stress with essential hypertension. 
Clinical and epidemiological studies indicate that chronic psychological stress can 
lead to essential hypertension [48, 49]. Many workers in their studies have found 
that individuals exposed to chronic stress show persistent hypertension [40, 50, 51]. 
Various population studies have demonstrated that psychosocial stress is associ-
ated with an increased risk of hypertension [52, 53]. Studies have also found that 
stress induced alterations in blood pressure persist even after the end of exposure to 
stressors [54, 55].
7.3 Possible mechanisms leading to essential hypertension
7.3.1 Increased activity of sympathetic nervous system
Chronic exposure to stressors leads to dysregulation of autonomic nervous 
system and increase in the activity of HPA axis. Dysregulation of ANS causes 
increase in the activity of sympathetic nervous system (SNS), which further 
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augments the activity of HPA axis [56]. Activation of SNS leads to enhanced 
release of NE, Nitric oxide (NO) and Neuropeptide Y (NPY) from sympathetic 
nerve terminals [57].
Stimulation of sympathetic nervous system is a pathophysiological hallmark of 
essential hypertension, and especially, hypertension attributable to chronic mental 
stress [40, 58, 59]. Increased SNS activity leads to the development of hypertension 
by several mechanisms like peripheral vasoconstriction, increased cardiac contrac-
tion, renal sodium and water retention, baroreflex dysfunction, and vascular dam-
age [60, 61]. Chronic sympathetic stimulation causes left ventricular hypertrophy 
and dysfunction, and arterial remodelling [62]. Repeated stress-induced vasocon-
striction may also result in vascular hypertrophy, leading to progressive increases in 
peripheral resistance and blood pressure [63].
NE and NPY modulate the release of pro-inflammatory cytokines, such as 
Interleukin-6 (IL-6), C-reactive protein (CRP), and tumour necrosis factor (TNF) 
[52]. These cytokines in turn cause inflammation and endothelial dysfunction and 
lead to development of hypertension [64].
The mechanisms underlying dysregulation of sympathetic nervous system activ-
ity involve impairment in sympathetic restraint due to alterations in arterial and 
cardio-pulmonary baroreflexes and central/peripheral chemoreflexes or error in the 
processing of reflex signals in brainstem cardio vascular centre [65]. Resetting of 
the baroreflex to a higher pressure and reduced baroreflex sensitivity are important 
mechanisms underlying essential hypertension [66, 67]. Resetting of baroreflex 
can be at afferent, central or efferent level [68]. Afferent component can be altered 
by defective mechanosensitive transduction in case of decreased vascular compli-
ance and loss of coupling of vessel wall stretch to baroreceptors [67]. Prolonged 
stimulation of CNS via baroreceptor afferents may result in remodelling of the 
neural networks involved in the processing of baroreceptor signals. CNS ‘rewiring’ 
may be contributing to the resetting, adaptation, and post excitatory depression of 
the baroreceptors. This resetting in CNS could be due to decreased responsiveness 
of the medullary autonomic regulatory centres to baroreceptor signalling. Central 
resetting of baroreceptors causes sympathetic activity to ‘escape’ the inhibitory 
effect of baroreflex [69]. Evidence also shows that angiotensin II, aldosterone and 
reactive oxygen species (ROS) may be involved in the centrally mediated changes 
in baroreflex efferent activity, which contribute to sympathetic over activity in 
hypertension [69].
Sympathetic outflow also affects renal regulation of blood pressure. Stimulation 
of the renal sympathetic outflow is thought to be a common final pathway in the 
pathogenesis of essential hypertension in chronic stress [51, 52]. The activation of 
renal sympathetic nerves underlines the concurrent ‘neural’, ‘renal’, and ‘sodium’ 
mechanisms leading to the development of hypertension. Stimulation of renal 
sympathetic nerves is believed to have direct and indirect effects (through RAAS) 
on renal ‘pressure-natriuresis’ mechanism inducing sodium and water retention, 
causing volume expansion and increased blood pressure [70].
7.3.2 Over activity of HPA axis
Dysregulation of HPA activity due to stress especially psychogenic stress, causes 
marked enhancement in basal HPA tone causing enhanced CRH and AVP synthesis 
[71], increase in the baseline glucocorticoid secretion, adrenal hypertrophy [72], 
down regulation of glucocorticoid receptors (GR) in feedback regions, such as hip-
pocampus and prefrontal cortex [71], enhancement of cortisol response to stressors 
[73], blunting of glucocorticoid negative feedback effect [74], and increased 
anxiety and depression [75].
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Activation of HPA axis involves increased secretion of CRH and AVP in the hypo-
thalamus. AVP in turn potentiates CRH activity [76]. CRH stimulates production of 
ACTH by the anterior pituitary gland. ACTH then acts on the adrenal glands to cause 
release of glucocorticoids (GCs), mainly cortisol and mineralocorticoids (MRs). In 
addition to being a principal regulator of the HPA axis, CRH also causes stimulation 
of SNS activity [77]. Glucocorticoids stimulate biosynthesis, secretion and release of 
catecholamines (CA) by sympathetic nerves and adrenal medullary cells [78], and 
enhance vasoconstrictor effects of angiotensin-II and catecholamines and it has also 
been implicated in endothelial dysfunction [79]. Thus, synergistic and prolonged 
actions of CRH, glucocorticoids and catecholamines cause central and autonomic 
dysregulation of cardiovascular system, which eventually leads to hypertension.
7.3.3 Renin-angiotensin-aldosterone system (RAAS)
Renin–angiotensin-aldosterone system (RAAS) plays an important role in the 
development of stress induced hypertension [80, 81]. Angiotensin II is the main 
effector of RAAS, which increases blood pressure by various mechanisms including, 
increase in the sympathetic outflow from the brain, constriction of resistance ves-
sels, stimulation of aldosterone secretion, increase in renal tubular sodium reab-
sorption directly and indirectly, stimulation of thirst, and release of AVP hormone 
[38]. Angiotensin II modulates ‘pressure natriuresis’ mechanism in the kidneys and 
contribute to the development of RAAS-dependent blood pressure dysregulation in 
hypertension [82].
Evidence suggests that activation of angiotensinergic pathways in the central 
nervous system (CNS) plays a critical role in the development of hypertension by 
circulating angiotensin II or aldosterone [10]. Most of the actions of angiotensin 
II are mediated by angiotensin II type 1 receptors (AT1), which are expressed in a 
number of brain regions like, circumventricular organs (CVOs), hypothalamus, 
brainstem and parts of limbic cortex associated with the emotional stress response 
like, the amygdala, bed nucleus of stria terminalis (BST) and other limbic regions 
[83]. Projections from limbic regions extend to the areas involved in autonomic 
control of blood pressure, namely, circumventricular organs (CVOs) including 
Subfornical organ (SFO) and organum vasculosum of the lamina terminalis (OVLT) 
[84]. Angiotensinergic sympatho-excitatory neurons in CVO project to the paraven-
tricular nucleus (PVN), and the PVN neurons in turn project to the rostral ventro-
lateral medulla (RVLM) in the brainstem or directly to the intermediolateral cell 
column in the spinal cord [85]. Circulating angiotensin II or angiotensin II released 
from nerve terminals bind to AT1 receptors and cause activation of presympathetic 
neurons thereby increasing SNS activity and blood pressure [86]. Thus, circulating 
angiotensin II acts as a major signal to the CNS that contributes to the development 
of hypertension. Angiotensin II not only exerts the central effects mentioned above 
to increase sympathetic outflow, but also has direct effects on postganglionic fibres 
to enhance the release of catecholamines [87].
Angiotensin II also promotes vasoconstriction [88], and is a potent stimulus for 
pro-inflammatory and pro-oxidative events leading to endothelial dysfunction, vas-
cular remodelling and eventual development of hypertension [89, 90]. Angiotensin 
II exerts vascular damage by generation of reactive oxygen species (ROS) and 
stimulation of redox-dependent signalling pathways [91].
7.3.4 Immune dysfunction and inflammation
Psychological stress can affect immune function by activating sympathoadrenal 
system (SAS) as well as the HPA axis to release catecholamines (adrenaline and 
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noradrenaline), ACTH, and glucocorticoids (cortisol). These stress hormones 
in turn induce immune modulation leading to production of pro-inflammatory 
cytokines, including C-reactive protein (CRP), tumour-necrosis factor (TNFα), 
Interleukin-6 (IL-6), Interleukin-1 (IL-1β), Interleukin-2 (IL-2), and the transcrip-
tion factor of nuclear factor kappa B (NF-κB) [92]. Immune modulation can also 
occur directly through the binding of the stress hormones to their receptors on the 
surface of the immune cells as almost all immune cells express receptors for one or 
more of the stress hormones [93].
Various studies suggest that hypertension is a state of chronic low grade inflam-
mation, that is characterised by the infiltration of immune cells into the interstitium 
of affected organs, (mainly kidneys, blood vessels, brain and heart), where they 
release pro-inflammatory cytokines and promote oxidative stress, which then leads 
to dysfunction of these organs, causing hypertension and eventual end-organ dam-
age [94, 95]. Thus, inflammation in the kidneys, vessels, and CNS plays a major role 
in the pathogenesis of hypertension [96].
Evidence shows that hypertensive patients have increased levels of circulating 
monocytes, lymphocytes and pro-inflammatory cytokines, such as tumour necrosis 
factor α (TNF-α), interleukin (IL) 6 and C-reactive protein [97]. Vascular inflam-
mation is characterised by an accumulation of macrophages, monocytes, dendritic 
cells, B and T lymphocytes; moreover, increased expression of pro-inflammatory 
cytokines and cell adhesion molecules in different layers of the vascular wall induce 
extracellular matrix deposition, smooth muscle hypertrophy, and endothelial 
dysfunction, contributing to the development and maintenance of arterial hyper-
tension [98]. Immune cells and cytokines stimulate formation of reactive oxygen 
species (ROS) by vascular smooth muscle cells and endothelial cells, which in turn 
causes endothelial dysfunction and hypertension [95].
Several studies show that hypertension is associated with accumulation 
T cells, monocyte/macrophages and dendritic cells in the kidneys. Cytokines 
secreted by innate and adaptive immune cells, as well as renal epithelial cells, 
modulate the expression and activity of sodium transporters along the neph-
ron, leading to defective pressure natriuresis, sodium and water retention, and 
hypertension [95, 99]. Cytokines produced by T cells, especially IL −17 A, play an 
important role in pathogenesis of hypertension due to renal inflammation. Renal 
inflammation, immune cell infiltration, and augmented angiotensin II activity 
blunt pressure dependent natriuresis and cause hypertension [100].
The central nervous system (CNS), the sympathetic nervous system (SNS), 
and the immune system are interconnected in the physiological modulation of 
hemodynamic and immune activity [101]. Inflammatory cells and cytokines can 
impair central autonomic control of blood pressure regulation [102]. CNS can serve 
as both a target for inflammatory cells in hypertension and as a mediator of inflam-
mation through its communication with the immune system. Angiotensin II is a key 
contributor to these processes in the setting of hypertension. Angiotensin II causes 
T cell activation and vascular inflammation especially in CVO region of the brain 
and leads to hypertension [103].
7.3.5 Oxidative stress and endothelial dysfunction
There is increasing evidence that oxidative stress is strongly associated with 
essential hypertension [104]. Many studies have shown that chronic psychologi-
cal stress promotes oxidative stress throughout the body [105, 106]. Oxidative 
stress occurs when there is over production of oxidant agents, reactive oxygen 
species (ROS) that overwhelm the cellular antioxidant defence system. Oxidative 
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stress causes endothelial dysfunction and thus contributes to the development of 
hypertension [107].
Endothelial dysfunction involves alteration of the endovascular lining of blood 
vessels that is characterised by a pro-thrombotic, pro-inflammatory, and pro-
constrictive phenotype [107]. An imbalance in the homeostasis of the endothelial 
derived relaxing factors like NO and prostacyclin (PGI2) and endothelial derived 
constricting factors like endothelin 1 (ET 1) and angiotensin II, is a major feature in 
endothelial dysfunction, that leads to functional changes in the microvasculature 
with a predominant and deleterious constrictive tone, which causes increased 
peripheral resistance and hypertension [108].
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) have an 
important role in the homeostasis of the vascular wall, hence they are implicated in 
the pathogenesis of hypertension [109]. The most important ROS within the vascu-
lature include the superoxide anion, hydrogen peroxide, hydroxyl radical and RNS 
being peroxynitrite. Physiologically, ROS generation is tightly regulated by endog-
enous cellular antioxidants, which include superoxide dismutase (SOD), catalase, 
thioredoxin, glutathione, and antioxidant vitamins [110]. In hypertension, there is 
a mismatch between ROS production and protective antioxidant mechanisms in the 
cells, leading to a state of oxidative stress [111].
Oxidative stress may contribute to the development and/or maintenance of 
hypertension via numerous mechanisms. ROS such as superoxide combines with 
nitric oxide (NO), to form peroxynitrite. This reduces bioavailability of NO causing 
impaired endothelial derived vasodilation [112]. Free radical induced generation 
of lipid peroxidation products, such as F2-isoprostanes have vasoconstrictor effect 
and thus can modulate the vascular tone [113]. Superoxide leads to oxidation of 
tetrahydrobiopterin (BH4), which promotes endothelial nitric oxide synthase 
(eNOS) uncoupling and causes further production of ROS [114]. ROS also adversely 
affects blood vessels leading to structural remodelling and vascular dysfunction 
[115]. When produced in excess, ROS has many deleterious effects that results in 
endothelial dysfunction, increased vascular contractility, vascular remodelling, 
vascular inflammation, growth of vascular smooth muscle cells and apoptosis, lipid 
peroxidation and deposition of extracellular matrix proteins, all the major processes 
involved in pathogenesis of hypertension [116, 117].
Evidence also suggests an interrelationship between immune response and 
oxidative stress. Oxidative stress induced immune activation mechanism have been 
proposed in the pathogenesis of hypertension [95, 118]. It has been proposed that 
oxidative stress-induced ROS causes production of ‘isoketals’ by fatty acid oxida-
tion, which serve as autoantigens [119]. Autoantigens then cause T cell proliferation 
and increased production of pro-inflammatory cytokines such as chemokine (C-C 
motif) ligand 2 (CCL2), IL-1, IL-6, IL-17A, and TNF-α in the kidneys, blood vessels 
and other tissues [89, 120]. These inflammatory mediators along with catechol-
amines and other blood pressure elevating hormones mutually exert their actions 
to cause vascular and renal dysfunction, which ultimately results in development of 
hypertension [119].
7.4  Mediators of inflammation and endothelial dysfunction: a possible causative 
link between stress and pathogenesis of essential hypertension
Chronic inflammation and endothelial dysfunction play a crucial role in the 
development and progression of essential hypertension [121–123]. Prolonged expo-
sure to stress generates, on the one hand, a state of chronic inflammation, which 
adversely affects the health and integrity of the endothelium [124]; and, on the 
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other hand, activation of the HPA axis and the SNS, which produce mediators that 
directly affect the organ systems involved in blood pressure regulation [125]. Some 
of the mediators which may be central to the inflammatory mechanisms contribut-
ing to the pathogenesis of hypertension are listed below.
7.4.1 Immune cells
As mentioned earlier infiltration of immune cells into the interstitium of kid-
neys, brain, heart, and blood vessels and release of cytokines cause inflammation 
and leads to the development of hypertension. It has been found that the number 
of circulating ‘immunosenescent’ pro-inflammatory CD8+ T cells is increased in 
hypertensive patients. These cells produce pro-inflammatory cytokines like IFN-γ 
and TNF-α, and the cytotoxic molecules, granzyme B and perforin [126]. These 
cells also express mineralocorticoid receptors, which play a major role in develop-
ment of systemic hypertension by promoting production of IFN-γ [127]. It has been 
shown that IL-17A, produced by CD4+ T cells and γ/δ T cells, plays a critical role in 
hypertension [128, 129]. Clinical and experimental hypertension is associated with 
raised serum IgG, IgA or IgM antibodies produced by B cells [130]. Autoantibodies 
that are agonistic to angiotensin type 1 receptor (AT1 R) are found to be present in 
hypertensive patients [131, 132]. Monocytes and macrophages have been implicated 
in various models of experimental hypertension [133, 134]. They accumulate in the 
perivascular tissue, adventitia and kidneys [135] and promote the release of pro-
inflammatory mediators and free radicals via NADPH oxidase 2 (NOX 2) to cause 
inflammation [136] Studies indicate that Dendritic cells (DCs) play a role in the 
development of hypertension. DCs in hypertensive animals produce an increased 
amount of superoxide and cytokines (IL-1ß, IL-6, IL-23), which affects T cell 
polarisation into the inflammatory phenotype [137].
7.4.2 Cytokines
Cytokines produced by immune cells have deleterious inflammatory effects 
on the kidneys, blood vessels, heart and brain. IL-17A contributes to angiotensin 
II (Ang II)-induced renal injury and modulates the expression of renal sodium 
transporters affecting pressure natriuresis [138, 139]. Interferon Gamma (IFN-γ) 
produced by TH1 cells, CD8+ T cells (TC1 cells) and natural killer T cells, affect 
local renin-angiotensin system and along with IL-17A, it is found to alter the 
expression of renal sodium transporters in proximal and distal tubules to directly 
affect pressure-natriuresis mechanism [139]. Tumour Necrosis Factor-α (TNF-α), 
produced by T cells, macrophages, and endothelial cells, decrease the renal tubular 
expression of eNOS affecting NO production, which leads to sodium retention 
[140, 141]. Interleukin 6 (IL 6) produced by dendritic cells, macrophages, mono-
cytes, and TH1 cells is considered to be a major signal to promote polarisation 
of CD4+ T cells to produce IL-17A [138]. IL-17A is implicated in the angiotensin 
induced hypertension [142].
Studies also show that IL-17A causes vascular dysfunction by increasing super-
oxide production and reduced NO production by impairing eNOS activity [94, 
128, 138]. TNF-α affects endothelial eNOS expression, affecting production of NO 
by endothelial cells [143]. TNF-α also activates NF-κB and NADPH oxidase [143], 
which causes induction of oxidative stress and overexpression of both chemokines 
and adhesion molecules [144]. IFN-γ causes superoxide production via upregulation 
of the expression and activity of NADPH oxidases in human aortic smooth muscle 
cells [145]. It acts directly on vascular smooth muscle cells to induce their prolifera-
tion and apoptosis [146]. IL-6 mediates elevation of superoxide production and 
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endothelial impairment by affecting NO-cGMP pathway [147]. IL-6 has also been 
reported to play a role in vascular smooth muscle cells migration and proliferation 
causing vascular medial hypertrophy [148].
7.4.3 Corticotropin-releasing hormone (CRH)
Besides being produced in nervous system, CRH is also an autocrine and 
paracrine mediator in tissues like endothelium. In vitro studies show that CRH 
dose-dependently induces the release of endothelin-1 (ET-1) [149], causes increase 
in reactive oxygen species (ROS) content, increased catalase activity, and peroxyni-
trite levels as well as a decrease in the activity of endothelial nitric oxide synthase 
(eNOS) and nitric oxide (NO) production [150]. It also cause increased vascular 
permeability, and cytokine release further affecting vascular health [151].
7.4.4 Glucocorticoids (GCs)
Circulating high level of GCs in hypertensive patients are believed to cause over-
production of ROS and reduced availability NO in the vascular endothelium. The 
GC-induced decrease in NO availability may elicit vascular endothelial dysfunction, 
leading to hypertension. GCs are also believed to stimulate release of vasoconstric-
tor endothelin 1 (ET 1) and increase vascular tone [56].
7.4.5 Endothelin 1 (ET 1)
ET-1 are powerful vasoconstrictor peptides produced by variety of tissues 
including vascular endothelium, heart, and kidney epithelial cells. The synthesis of 
ET-1 is stimulated by angiotensin II, AVP, norepinephrine, glucocorticoids, hypoxia, 
shear stress, lipoproteins, oxidative stress [152] and of particular interest, by acute 
mental or physical stress [153]. Studies have shown that ET-1 at the central level 
plays an essential role in the cardiovascular sympathetic response to stress [154]. 
Besides its vasoconstrictive action, ET-1 causes fibrosis of the vascular wall, mitotic 
stimulation of vascular smooth muscle, increased production of ROS (superoxide) 
and is pro-inflammatory [155]. ET 1 contributes to the development of inflamma-
tory mechanisms by activating transcription factor-κB, and by increasing produc-
tion of pro-inflammatory cytokines like, TNFα, IL-1, and IL-6. ET 1 also induces 
cyclooxygenase-2 (COX-2) expression and prostaglandin E2 (PGE 2) release by 
mitogen-activated protein kinase (MAPKs) and NF-κB. Cyclooxygenase-2 is 
involved in the development of vascular inflammation [156].
7.4.6 Angiotensin II and aldosterone
Angiotensin II induces an inflammatory response in the kidneys, heart and 
vasculature by increasing the expression of pro-inflammatory chemokines, and 
also causes T cell mediated inflammation [157]. Angiotensin II is one of the major 
vasoactive peptides involved in the regulation and activation of NAD(P)H oxidase, 
a major source of ROS in the vascular wall, and thus, it contributes to the produc-
tion of ROS in vascular smooth muscle cells and endothelial cells [110]. Through 
ROS generation, angiotensin II exerts several deleterious vascular effects, including 
functional and structural changes, which results in hypertension [158]. Angiotensin 
II also promotes endothelial dysfunction through cyclooxygenase-2 (COX-2) activa-
tion, which generates vasoactive thromboxane A2 and ROS [159].
Aldosterone has been reported to exert mineralocorticoid receptor medi-
ated pro-inflammatory effects in vessels, heart and kidneys [64]. It induces 
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inflammation by stimulating the formation of reactive oxygen species such as 
superoxide and hydrogen peroxide [160]. In the heart, aldosterone can increase 
vascular expression of intracellular adhesion molecule-1 (ICAM-1), monocyte che-
motactic protein-1 (MCP-1), osteopontin, and COX-2, to cause inflammation [161]. 
In the kidneys, aldosterone has been shown to cause inflammation by leukocyte 
infiltration and elevation of osteopontin, IL-6, IL-1𝛽, and MCP-1 levels [162].
7.4.7 Reactive oxygen species (ROS) and reactive nitrogen species (RNS)
ROS/RNS are strongly implicated in the pathogenesis of hypertension by causing 
oxidative stress, endothelial dysfunction and inflammation. ROS are derived from 
oxygen reduction which produces, through several steps, important intermediate 
products: superoxide anion, hydrogen peroxide, and hydroxyl radical [104] Some 
of the enzymes involved in ROS generation are: nitric oxide synthase, peroxidases, 
NADPH oxidase, NADPH oxidase isoforms (NOX), xanthine oxidase (XO), lipoxy-
genases (LOXs), glucose oxidase, and cyclooxygenases (COXs) [163]. RNS derives 
from nitric oxide (NO) that is generated by the NADPH-dependent enzyme nitric 
oxide synthase [164]. NO is a free radical but is relatively stable. NO is able to form 
other nitrogen reactive intermediates (nitrate, peroxynitrite, and 3-nitrotyrosine), 
which affect cell functions [165].
ROS are potent modulators of vascular contraction, dilatation, and structural 
remodelling by processes such as reducing bioavailability of NO by superox-
ide anion (O2−), generation of vasoconstrictor lipid peroxidation products 
(F2-isoprostanes), depletion of tetrahydrobiopterin (a key cofactor for NO syn-
thase), activation of pro-inflammatory transcription factors, stimulation of growth 
factor production, and induction of fibrosis through activation of matrix metal-
loproteinase [166]. These processes induce increased intracellular calcium, activa-
tion of growth and inflammatory signalling pathways, and increased extracellular 
matrix deposition, leading to endothelial dysfunction, increased vascular smooth 
muscle reactivity, and vascular remodelling [167]. All of these factors contribute to 
the development of hypertension.
8. How does stress cause hypertension?
The answer to this question is not simple or straight forward. However, it is 
evident from the above discourse that stress, especially chronic psychological stress 
directly affects neuro-endocrinal control of blood pressure regulatory systems and 
contribute to the development and progression of essential hypertension. Central 
to the pathogenesis of hypertension is the over activity of SNS and HPA axis. 
Increased sympathetic outflow and HPA system hyperactivity act synergistically to 
potentiate the actions of each other and results in a cascade of deleterious effects on 
the various inter-connected organ systems involved in blood pressure regulation. 
Principle among these organs are kidneys, brain, heart and blood vessels, which 
may suffer eventual structural and functional deterioration. The consequences of 
these effects are baroreflex dysfunction, stimulation of RAAS activity, activation 
of immune cells, oxidative stress and endothelial dysfunction. The end result of 
these effector mechanisms is manifested in several different ways affecting the 
target organs; in kidneys, altered pressure dependent natriuresis leading to sodium 
retention and fluid volume expansion, in blood vessels, vascular inflammation, 
increased vascular contractility, vascular remodelling and arterial stiffness all caus-
ing increased peripheral resistance, and in heart, cardiac injury, fibrosis of heart 
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and cardiac hypertrophy. Combination of all these factors eventually  
lead to the development of essential hypertension.
9.  Yoga as a therapeutic intervention for the management of essential 
hypertension
Yoga is an ancient Indian discipline designed to bring balance and health to 
the physical, mental, emotional, and spiritual dimensions of the individual [168]. 
Numerous studies have shown yoga to have beneficial effects on cardio-vascular 
indices in hypertensive patients. The exact underlying mechanisms of the benefi-
cial effects of yoga in hypertension still remain elusive. However, there is a reason 
to believe that yoga may be having multiple and simultaneous effects on diverse 
neuro-endocrine regulatory structures to cause neurohumoral modulation resulting 
in alleviation of stress and improvement in cardiovascular behaviour. Thus, yoga 
seems to have beneficial effects in essential hypertension by two-way action of 
simultaneously influencing blood pressure regulatory mechanisms as well as stress 
regulatory mechanisms.
Various neurophysiological mechanisms have been proposed in previous studies 
to explain the beneficial effects of yoga therapy in hypertension. Following sections 
describe some of the possible neuro-endocrine mechanisms underlying the benefi-
cial effects of yoga in essential hypertension.
9.1 Down-regulation of HPA axis and SNS activity
There is increasing evidence that yoga appears to have widespread beneficial 
effects on the cardiovascular response to stress in healthy and hypertensive indi-
viduals through down-regulation of the HPA axis and the sympathetic nervous 
system (SNS) [168, 169].
In various studies, it has been found that regular practitioners of yoga asanas 
showed a significant reduction in the blood levels of adrenaline, noradrenaline 
and plasma rennin activity [170, 171]. The attendant reduction in catecholamines 
and cortisol, decline in cardiovascular reactivity, enhancement of mood and 
well-being, and alleviation of perceived stress may result in positive downstream 
effects on metabolic and hemodynamic profiles [168, 171, 172]. Yoga thus signifi-
cantly decreases heart rate and systolic and diastolic blood pressure probably by its 
quietening effect on HPA axis and SNS activity [168, 171, 173].
Down regulation of HPA axis and SAS by yoga may be brought by the actions 
of yoga on different neural structures involved in stress response and cardiovas-
cular regulation. It has been proposed that yoga may be acting at the level of the 
paraventricular nuclei (PVN) of the hypothalamus, which is a principal integra-
tor of stress signals involved in regulating HPA axis and autonomic responses to 
stressors. Evidence suggests that the yogic practices probably inhibit the activity of 
PVN with the resultant decrease in ACTH release from anterior pituitary which in 
turn decreases the synthesis of cortisol from the adrenal glands [174]. Cortisol also 
tends to activate phenyl ethanolamine-N -methyl transferase (PNMT) required for 
conversion of norepinephrine to epinephrine. Consequent to sympathetic inhibition 
and a decrease in PNMT, catecholamine formation decreases. The decreased levels of 
corticosteroids and catecholamines are known to decrease stress responses [174, 175].
Yoga may also be causing inhibition of the posterior hypothalamus to decrease 
sympathetic activity and thus, may restore autonomic balance between sympathetic 
and parasympathetic limbs to alleviate stress [174–176].
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Yoga may also be acting at the level of limbic cortex and/or higher cortical 
centres to modulate autonomic response to stress. It has been proposed that regular 
practice of yoga results in modulation of autonomic response such that there is a 
predominant parasympathetic effect and reduced sympathetic tone, which causes 
reduction in heart rate and blood pressure. Furthermore, it is suggested that this 
modulation of autonomic balance may be mediated through the limbic system and 
higher cortical areas resulting in the inhibition of posterior nuclei of hypothalamus 
leading to decreased discharge through descending autonomic fibres [176–178].
Studies have also shown that regular practice of yoga is associated with the 
reduction in the basal cortisol and catecholamine secretion, decrease in sympathetic 
activity with the corresponding increase in parasympathetic activity [179]. It is 
believed to be due to the alleviation of stress by yoga. Stress relieving effect of yoga 
may be due to modulation of limbic signals, which may alter sympathetic activity 
and hormonal response during stress via hypothalamus [180, 181]. Yoga might also 
be involved in upregulation of hippocampal 5HT1A receptors leading to decrease in 
cortisol levels and thus helping to relieve stress [179].
In a study, which assessed the effect of yoga based guided relaxation on auto-
nomic variables, it was found that there was a decrease in heart rate and skin con-
ductance levels along with the decrease in power of the low frequency component 
of heart-rate variability and increase in the power of high frequency component, 
which could be attributed to decreased sympathetic tone after guided relaxation 
[182]. In other studies involving yoga intervention in depressed patients, significant 
reductions in low-frequency heart rate variability (HRV); a sign of sympathetic 
nervous system activation, was noted following yoga intervention [168, 183].
Regular practice of slow pranayamic breathing is also known to reduce sym-
pathetic nerve traffic and increase parasympathetic activity [184, 185]. One of 
the long-term effects of pranayamic breathing is the improvement in autonomic 
function. Specifically, with slow breathing pranayama there is a noted increase 
in parasympathetic activity and a decrease in sympathetic dominance [177, 184]. 
Short-term effects of slow pranayamic breathing include increased galvanic skin 
resistance, decreased heart rate, decreased blood pressure and increased amplitude 
of theta waves indicating increased parasympathetic activity. Both the short term 
and long-term effects of pranayamic breathing indicate a dynamic alteration of 
the autonomic system tilting the balance in favour of parasympathetic dominance 
[184, 186]. It is proposed that slow deep pranayamic breathing shifts the autonomic 
balance to parasympathetic dominance by two mechanisms: (1) Inflation of lungs 
above tidal volume during pranayama stimulates stretch receptors in the lungs. 
Stimulation of stretch receptors increases the frequency and duration of inhibitory 
neural signals that are known to elicit synchronisation of neural activity in the 
cardio-respiratory centre in the brainstem [187] and CNS especially hypothalamus 
[188]. Synchronisation within the hypothalamus and the brainstem [189] may be 
responsible for inducing the parasympathetic response [190] during breathing 
exercises. (2) Pranayama also causes stretching of connective tissue (fibroblasts) 
localised around the lungs. Hyperpolarisation is generated in the stretched lung 
fibroblasts, which induces generation of slower brain wave activity and parasympa-
thetic shift of ANS [184]. Hyperpolarisation affects the autonomic nervous system 
by modulating neuronal excitability [191], resting membrane potential [187], and 
generating rhythmic brain activity [188].
9.2 Increased vagal activity
It is proposed that by stimulating the vagus nerve activity, yoga may enhance 
parasympathetic output and thereby shift the autonomic balance from primarily 
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sympathetic to parasympathetic that may buffer the effects of stress leading to 
positive changes in the cardiovascular, neuroendocrine, and metabolic responses to 
stress with the resultant decrease in heart rate and blood pressure [172].
It has been proposed that the positive effects of yoga may be mediated by increased 
vagal activity and consequent reduction in cortisol. This may likely happen via stimu-
lation of dermal and/or sub dermal pressure receptors that are innervated by vagal 
afferent fibres, which ultimately project to the limbic system and also hypothalamic 
structures involved in regulating cortisol secretion. These pathways are supported by 
anatomical studies indicating that baroreceptors and mechanoreceptors within the 
dermis (i.e. Pacinian corpuscles) are innervated by vagal afferent fibres. Yoga may 
thus increase vagal activity via stimulation of pressure receptors and cause decrease in 
cortisol levels [192]. Vagal stimulation promotes down regulation of the hypothalamic-
pituitary-adrenal (HPA) axis and the sympathetic nervous system (SNS) [168, 172]. 
As a result there is a decrease in the release of cortisol and catecholamines leading to 
reduction in the heart rate and systolic and diastolic blood pressure [193].
In addition, tactile sensory stimulation is conducted through the vagal afferents 
directly to medulla oblongata in the nucleus of the solitary tract (NTS). Axons 
from NTS then project to the dorsal motor nucleus of the vagal nerve and the PVN 
neurons containing oxytocin that mainly influence the NTS regulation of the heart 
rate and indirectly the blood pressure [194]. Initial studies indicate stress-reducing 
effects of oxytocin in humans, as increased levels of oxytocin serve to suppress 
both sympathetic arousal and HPA) axis responses to stress [195]. Many studies in 
humans found support for a negative relationship between basal plasma oxytocin 
levels and norepinephrine, blood pressure, and heart rate [196].
In studies employing ‘Sudarshan Kriya Yoga’, a yogic breathing technique, it 
was found that physiological responses to stress improved through mechanisms 
involving both afferent vagal activity (altering CNS behaviours) and efferent vagal 
activity, as well as through decreased chemoreflex sensitivity and improved baro-
reflex response [197, 198]. In another study it was found that long term practice of 
yogic breathing enabled body to tolerate exercise induced higher levels of carbon 
dioxide by decreasing chemoreflex sensitivity mediated via vagus nerve [199]. It 
has been proposed that adaptation of peripheral/central chemoreceptors to chronic 
carbon dioxide retention or adaptation of pulmonary stretch receptors to a habit 
of slow respiration may increase vagal afferent discharge to the brainstem centre 
NTS. Vagal nerve afferents synapse in the medulla on the nucleus tractus soli-
tarius (NTS), which in turn communicates to the thalamic nuclei via parabrachial 
nucleus (leading to modulatory effects on cerebral cortex) and the limbic system. 
Through the limbic system directly or indirectly through subcortical areas, the 
neuroendocrine outputs are then modulated, resulting in the reduction of cortisol 
and increase in oxytocin, and prolactin secretion. These vagal effects are physically 
and emotionally calming and help in alleviation of stress [200, 201].
9.3 Restoration of baroreflex sensitivity
The arterial baroreflex acts to buffer acute changes in blood pressure by recip-
rocal modulation of sympathetic and parasympathetic activity that controls the 
heart and vasculature [202]. Baroreflex sensitivity indicates cardiovagal adapt-
ability allowing greater responsiveness and sensitivity to changing environmental 
demands [172]. Vagal stimulation increases heart rate variability (HRV) and 
baroreflex sensitivity [203]. HRV is a cyclic variation in the beat-to-beat interval 
that results from the tonic firing of cardiac-vagal efferents originating in the 
medulla. High HRV and baroreflex sensitivity are generally considered to indicate 
cardiovagal adaptability and sympathovagal balance [203].
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Yoga breathing exercises and postures are known to have immediate beneficial 
effects on heart rate variability and baroreflex sensitivity with reductions in heart 
rate and blood pressure [171, 172, 182, 204]. These effects are thought to reflect 
direct stimulation of the vagal nerve [171, 172].
Practice of yogic postures has been shown to restore baroreflex sensitivity lead-
ing to blood pressure reduction [171]. It is suggested that strong mechanical pres-
sure at the neck by some yogasanas like ‘halasana’ and ‘sarvangasan’ can increase 
arterial pressure (locally) so as to stimulate carotid baroreceptors to activate 
baroreceptor reflex mechanism leading to reduction in the heart rate and fall in the 
blood pressure via parasympathetic stimulation as in relaxation technique [205].
In a study conducted in the patients of essential hypertension (EH), it was found 
that at the end of 3 weeks of yoga course, the head-up and head-down tilt yogasanas 
restored baroreflex sensitivity to normal and reduced blood pressure significantly. 
It was suggested that once the sensitivity of baroreceptor mechanism was restored, 
it corrected all other neurohormonal malfunctioning, which was evident from the 
reduction in sympathetic activity, blood catecholamines, plasma rennin activity [171].
In another study exploring the effects of aerobic exercise training and yoga, on 
the baroreflex sensitivity in sedentary, healthy, normotensive elderly persons, it was 
found that, after 6 weeks of yoga training, the heart rate decreased in yoga group 
[204]. There was increased alpha-index at High Frequency (HF) reflecting para-
sympathetic activity but alpha-index at mid frequency (MF) (reflecting sympa-
thetic activity as well) was not increased. However, short-duration aerobic training 
did not modify the alpha-index at MF or at HF in aerobic group [204].
Besides yogasanas, yogic breathing is also known to increase baroreflex sen-
sitivity. In a study investigating the effect of a single session of slow breathing (6 
breaths/minute) in healthy subjects, there was increased baroreflex sensitivity and 
reduction in chemoreflex sensitivity [206]. This seemed to occur through a relative 
increase in vagal activity and a corresponding decrease in sympathetic activity. The 
increase in tidal volume could be responsible for these autonomic changes through a 
reduction in sympathetic activity or via the Hering-Breuer reflex. Reduced sympa-
thetic activity may be linked to a reduction of chemoreflex overactivity due to the 
reciprocal influences of the baroreflex and chemoreflex [207].
In yet another study on the patients of essential hypertension, slow breathing 
increased baroreflex sensitivity and reduced sympathetic activity and reduced chemo-
reflex activity, suggesting a potentially beneficial effect of yogic breathing technique in 
hypertension [208]. It has been proposed that slow breathing may enhance baroreflex 
sensitivity through increased vagal activity and decrease in sympathetic activity. 
Besides this, slow breathing may also cause increase in tidal volume and activate 
Hering–Breuer reflex, an inhibitory reflex triggered by lung stretch receptors and 
mediated by vagal afferents, which may increase baroreflex sensitivity. It has been also 
suggested that slow breathing may increase oxygen absorption that follows increased 
tidal volume, this may cause reduction in chemoreflex sensitivity, which in turn may 
result in increased baroreflex sensitivity via their reciprocal relationship [206–208]. It 
has also been proposed that, the nucleus tractus solitarius (NTS) acts as an integrating 
centre for baroreflex, chemoreflex and Hering-Breuer reflex and plays an important 
role in the effect of breathing on cardiovascular modulation and blood pressure reduc-
tion. However, the exact mechanism of such integration is not clear [209].
9.4 Action of yoga on GABA
GABA is essential as a negative regulator of neuronal excitability in the PVN, 
thus mediating the amplitude and the duration of the stress response [210]. One of 
the major mechanisms responsible for inhibition of HPA axis is the direct neural 
19
Stress, Hypertension and Yoga
DOI: http://dx.doi.org/10.5772/intechopen.88147
inhibition of PVN neurons by the neurotransmitter GABA [210, 211]. The neuro-
circuitry data suggest that GABA-containing pathways might comprise a key com-
ponent of the abnormalities in the HPA axis seen in human stress pathology [12]. 
It is suggested that impaired GABAergic control of PVN neurons may contribute to 
the elevated sympathetic drive in hypertension [212].
Yoga may be modulating HPA axis and SNS response at the level of PVN by its 
effect on GABA system. It has been shown that practice of yoga asanas results in 
significant increase in brain GABA levels especially in thalamus [213]. It is sug-
gested that increase in brain GABA levels following yogic intervention may be due 
to the ability of yoga practices to increase the activity of parasympathetic nervous 
system (PNS) by stimulating vagal afferents [213, 214]. Inhibitory influences from 
thalamus over the stress axis probably may be acting by way of BST-GABAergic 
inputs to PVN [215].
Thus, the beneficial effects of yoga appear to be mediated through several 
mechanisms including down regulation of HPA axis and sympathoadrenal system, 
stimulation of vagus to shift the autonomic balance towards parasympathetic domi-
nance, enhancement of baroreflex sensitivity, and increase in brain GABA levels so 
as to inhibit PVN, the integrator area of stress signals.
10. Conclusion
Stress disturbs homeostasis of the body, which results in a series of neuroendo-
crine and behavioural responses aiming to cope with the challenges evoked by the 
stressors. However, chronic exposure to stressors can turn the protective adaptive 
responses into self-perpetuating vicious cycle of deleterious effects on various 
systems of the body, including cardiovascular, renal, immune, and nervous system, 
which finally culminates into pathological conditions like essential hypertension. 
Yogic intervention exerts its beneficial effects by acting through several different 
mechanisms and modulates neuro-endocrine control of stress response and car-
diovascular behaviour. Thus, yoga has two-way action, at one level it tones down 
neuro-humoral response to stress and at another level, it brings about improvement 
in the cardiovascular indices in essential hypertension.
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